SARS-CoV-2-IN-107 (Compound A7) is an inhibitor of SARS-CoV-2 3CLpro, with an IC50 of 261.3 nM. It inhibits the replication of SARS-CoV-2, exhibiting an EC50 of 11.7 µM. Additionally, SARS-CoV-2-IN-107 demonstrates anti-inflammatory activity in LPS-stimulated RAW264.7 macrophages, with a NO inhibition rate of 68.6%.
Molecular Weight:
274.244
Formula:
C15H11FO4
Target:
SARS-CoV|||Virus Protease|||NO Synthase
T204279
* VAT and and shipping costs not included. Errors and price changes excepted
